This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase IV, open-label single-arm study investigat...
Clinical trial

A phase IV, open-label single-arm study investigating the pharmacokinetics and pharmacodynamics of the antiretroviral combination of rilpivirine and ritonavir-boosted darunavir in therapy-naive HIV-1 infected patients.

Read time: 1 mins
Last updated:8th Oct 2012
To see how well the study regime suppresses the HIV-1 virus after 48 weeks of therapy.
Category Value
Study start date 2012-10-08

View full details